{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "50242-109",
      "generic_name": "rituximab and hyaluronidase",
      "labeler_name": "Genentech, Inc.",
      "brand_name": "Rituxan Hycela",
      "active_ingredients": [
        {
          "name": "RITUXIMAB",
          "strength": "120 mg/mL"
        },
        {
          "name": "HYALURONIDASE (HUMAN RECOMBINANT)",
          "strength": "2000 U/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "50242-109-01",
          "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-109-01)  / 13.4 mL in 1 VIAL, SINGLE-DOSE",
          "marketing_start_date": "20170622",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "b81e9b67-233a-440d-aed6-95eaa6c9b4fa",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20170622",
      "product_id": "50242-109_b81e9b67-233a-440d-aed6-95eaa6c9b4fa",
      "application_number": "BLA761064",
      "brand_name_base": "Rituxan Hycela",
      "pharm_class": [
        "CD20-directed Antibody Interactions [MoA]",
        "CD20-directed Cytolytic Antibody [EPC]",
        "Endoglycosidase [EPC]",
        "Glycoside Hydrolases [CS]"
      ]
    }
  ]
}